Korea should depend on biopharmaceuticals

Domestic drug makers should focus on research and development of new biodrugs to survive in an era of the Korea-U.S. FTA via closer collaboration among related circles to innovate internal structures, said Chung Koo-hun Samsung Economic Institute on May 3.

They should pursue the knowledge-intensive industry based on research and development, away from the labor-intensive industry centering o...